Aarey Drugs & Pharmaceuticals Share Price

NSE
AAREYDRUGS •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Aarey Drugs & Pharmaceuticals Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
57.43% Gain from 52W Low
-12.6
TTM PE Ratio
Below industry Median
27.7
Price to Book Ratio
Low in industry
1.3
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is less than 1
0.2

Aarey Drugs & Pharmaceuticals Ltd shareholding Pattern

Promoter
45.4%
Foreign Institutions
2.8%
Public
51.8%
Promoter
45.3%
Foreign Institutions
3.4%
Public
51.3%
Promoter
45.3%
Foreign Institutions
3.4%
Public
51.3%
Promoter
50%
Foreign Institutions
3.8%
Public
46.1%
Promoter
50%
Foreign Institutions
3.9%
Public
46%
Promoter
50%
Foreign Institutions
3.9%
Public
46%

Aarey Drugs & Pharmaceuticals Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
5
Bearish Moving Averages
11
5Day EMA
58.60
10Day EMA
59.10
12Day EMA
59.20
20Day EMA
59.50
26Day EMA
59.80
50Day EMA
60.40
100Day EMA
59.70
200Day EMA
56.50
5Day SMA
58.20
10Day SMA
59.50
20Day SMA
59.70
30Day SMA
59.30
50Day SMA
60.60
100Day SMA
62.00
150Day SMA
57.50
200Day SMA
55.00
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
12954 Rs
12954 Rs
Week Rs
18294 Rs
18294 Rs
Month Rs
23442 Rs
23442 Rs
Resistance & Support
59.01
Pivot
Resistance
First Resistance
59.07
Second Resistance
59.17
Third Resistance
59.23
Support
First Support
58.91
Second support
58.85
Third Support
58.75
Relative Strength Index
46.79
Money Flow Index
40.28
MACD
-0.54
MACD Signal
-0.32
Average True Range
1.93
Average Directional Index
14.52
Rate of Change (21)
7.81
Rate of Change (125)
28.76

Aarey Drugs & Pharmaceuticals Ltd Company background

Founded in: 1990
Managing director: Mihir R Ghatalia
Aarey Drugs Pharmaceuticals Ltd was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles Chemicals Pvt Ltd. The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana. In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the company and the company was converted into public limited company. Also, the name of the company was changed from Niharika Textiles Chemicals Pvt Ltd to Aarey Drugs Pharmaceuticals Ltd.The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, APIs Drugs, Food Colours and Flavours. The company is engaged in the business of manufacturing, selling of drugs pharmaceutical products and is governed by a number of central and state legislations that regulate the business. Apart from the bulk drug manufacturing activity, they also undertake importing distributing of various industrial chemicals solvents throughout the country. The company has their manufacturing unit located at Thane.The companys products include Methyl Nitro Imidazole, Metronidazole Metronidazole Benzoate. Their pharmaceutical products are sourced from the authentic vendors to assure the quality and effectiveness. The pharmaceutical products offered by the company are in compliance with IP/ BP/ CP/ USP standards. They have their registered office is located at Thane and their corporate office is located at Mumbai.The company was established with the main object setting up manufacturing facilities for Bulk Drugs. In the year 1993, the company came with a public issue of 27,50,000 equity shares of Rs 10 each for cash at par aggregating to Rs 275 lakh. Also, the company shares were listed on the BSE, ASE DSE.In May 2009, the company plant started to upgrade the existing plant into international standards.In June 2016, the Company commenced manufacturing of Mono Methyl Urea Di Methyl Urea. In 201718, it added new products i.e. Erithromycin Derivates Mafenamic Acid with capacity of 10 m.t. 25 m.t. respectively in June 2017. In 201819, it commenced manufacturing of products i.e. Ortho Para Nitro Anisole, 2Bromomethyl1,3 dioxolane, and Mefenamic Acid. It also commenced manufacturing products i.e.Metformin Urasil.
Read More

Aarey Drugs & Pharmaceuticals Ltd FAQs

Aarey Drugs & Pharmaceuticals Ltd shares are currently priced at 58.8 on NSE and 59 on BSE as of 12/20/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Aarey Drugs & Pharmaceuticals Ltd [AAREYDRUGS] share was 29.08. The Aarey Drugs & Pharmaceuticals Ltd [AAREYDRUGS] share hit a 1-year low of Rs. 37.35 and a 1-year high of Rs. 74.8.

The market cap of Aarey Drugs & Pharmaceuticals Ltd is Rs. 164.82 Cr. as of 12/20/2024 12:00:00 AM.

The PE ratios of Aarey Drugs & Pharmaceuticals Ltd is 23.78 as of 12/20/2024 12:00:00 AM.

The PB ratios of Aarey Drugs & Pharmaceuticals Ltd is 1.21 as of 12/20/2024 12:00:00 AM

You can easily buy Aarey Drugs & Pharmaceuticals Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -